Viking Therapeutics - New Considerations And Updates From Biotech Showcase
Seeking Alpha,
Research Coverage- Viking Therapeutics ( VKTX ) This is meant as a scientific/business development post as to the merits of VKTX.
Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia
Overview of attention for article published in American Heart Journal, January 2005
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (90th percentile)
Readers on
- mendeley
- 64 Mendeley